#TITLE_ALTERNATIVE#

• Main Author: CANDIDA ARSA NIM : 11614012, NABILA
• Format: Final Project
• Language: Indonesia
• Online Access: https://digilib.itb.ac.id/gdl/view/29445
• Institution: Institut Teknologi Bandung

The drug information service is a pharmaceutical service that must be given by the pharmacist to improve <br /> <br /> adherence so that therapy can be achieved optimally. This study was conducted to determine the quality <br /> <br /> of drug information services, patient compliance, the effectiveness of hypertension therapy, and the <br /> <br /> relationship of these three parameters that were implemented at Ibrahim Adjie Bandung Community <br /> <br /> Health Center. This descriptive study was designed cross-sectional and concurrent (January - March 2018) <br /> <br /> using a validated questionnaire. The number of study subjects was calculated from the population of <br /> <br /> hypertensive patients using the Slovin formula. The quality of drug information services was measured <br /> <br /> using the SERVQUAL method, the adherence level was measured using Modified Morisky Scale (MMS), <br /> <br /> and the effectiveness of the therapy was analyzed by measuring the achievement of the patient's blood <br /> <br /> pressure according to the target set by JNC standard 7. There were 57 Prolanis and 302 non-Prolanis <br /> <br /> patients analyzed in this research. The quality of drug information services to both Prolanis and nonprolanis patients is good, ie 95% with the lowest value in facility dimension. Levels of adherence and <br /> <br /> effectiveness in Prolanis patients were 96.49% and 56.14% higher than those in non-Prolanis patients <br /> <br /> 31.13% and 26.16%. There was a positive correlation between the quality of drug information service with <br /> <br /> the effectiveness of therapy (r = 0.561, p> 0.05), and the higher level of patient adherence to therapeutic <br /> <br /> regimen the higher the effectiveness of the therapy (r = 0.842, p = 0.035). Types of drug information <br /> <br /> required by the patient but not consistently given by the pharmacist are side effects, warning / attention, <br /> <br /> drug interactions, contraindications, and drug classes. This research data demonstrates the need to <br /> <br /> improve the quality of drug information as well as other efforts such as prescription assessment, drug <br /> <br /> counseling / consultation to improve patient compliance with the regimen so as to improve the <br /> <br /> effectiveness of the therapy. <br />